Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Cardiotoxicity|HER2-positive Breast Cancer|Heart Failure|Cancer, Therapy-Related
Interventions: OTHER: Phased withdrawal of heart failure medications
Sponsor: University College, London
Collaborators: British Heart Foundation|Barts & The London NHS Trust|University College London Hospitals